Procter & Gamble Health Ltd.
Fundamentals
- Market cap
- ₹10,346 cr
- P/E
- 31.65×
- ROE
- 43.66%
- Debt / equity
- 0.00
- Div yield
- 3.28%
- 52-week range
- 4707.00 — 6739.00
Company snapshot
Procter & Gamble Health Ltd.
Pharmaceuticals
₹10,359 cr
P/E 31.69×
Latest quarter · Mar 2026
Sales₹370 cr
Net profit₹95 cr
Op. margin+36.6%
EPS₹56.99
Strength & growth
Debt / equity0.00×
Current ratio2.44×
Sales CAGR+3.9%
EPS CAGR+20.3%
The timeline — 3 notes on Procter & Gamble Health Ltd.
May 2026
- 26 May 26 · 5:31 PM IST Brief Brief · Earnings · Mid cap
Procter & Gamble Health posts 30% profit growth for FY26
The company closed the year with ₹327 crore in profit as Q4 momentum accelerated. Shareholders will receive a total dividend of ₹205 per share.
- 26 May 26 · 4:57 PM IST Brief Brief · Earnings · Mid cap
P&G Health's Q4 profit jumps 55% on strong pharma demand
Annual net profit reached ₹327 crore. The board has declared a final dividend of ₹45 per share, taking the full-year payout to ₹205.